UK's Medical Research Council identifies two drugs with potential in Alzheimer's

Scientists from the UK’s Medical Research Council (MRC) have identified two drugs which have the potential to block a pathway that leads to brain cell death, offering hope for a potential therapy in dementias such as Alzheimer’s and Parkinson’s.

The MRC is a publicly-funded charitable body that carries out research in a network of universities and hospitals across the UK.

The team made headlines in 2013 with the discovery of a chemical that, for the first time, was shown to prevent neurodegeneration, using mouse models.